Challenging headlines are the natural consequence of disrupting a very stale debate

April 15, 2025 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Ask this question - if Australian decision-makers can disregard the human impact of delays in reimbursed access to health technologies, why should they be excused from considering the broader consequences? …

Subscribe now to continue reading.

Latest Video

NSW Premier opens Australia’s first large-scale health translation hub at UNSW
November 24, 2025 - Latest News
Australia has 'all the ingredients' but has to decide what kind of health system it wants
November 26, 2025 - BioPharma
Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high
November 26, 2025 - Latest News
Scorecard reveals Australia is still ignoring its deadliest and most costly cancer
November 26, 2025 - Latest News
Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science
November 26, 2025 - Latest News

Challenging headlines are the natural consequence of disrupting a very stale debate

This is a preview of subscriber content

Latest Video

Most Read

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

Australia has 'all the ingredients' but has to decide what kind of health system it wants

Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high

Scorecard reveals Australia is still ignoring its deadliest and most costly cancer

Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science

New Stories

Imugene and JW Therapeutics join forces on first-in-class combination for solid tumours

Algorae Pharmaceuticals secures new supply of chemotherapy for Australia through Dr Reddy’s partnership

An interview that reminds us of the missing discussion in Australia

Neurizon Therapeutics entering 'a promising new horizon” as ALS program advances

Slade Pharmacy marks anniversary with record research contributions at conferences

US secures significant price reductions on 15 medicines in second round of medicare negotiations

The US and UK edging closer to an agreement on pharmaceutical pricing

Sign In

Challenging headlines are the natural consequence of disrupting a very stale debate

This is a preview of subscriber content

Latest Video

Most Read

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

Australia has 'all the ingredients' but has to decide what kind of health system it wants

Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high

Scorecard reveals Australia is still ignoring its deadliest and most costly cancer

Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science

Follow Us

New Stories

Imugene and JW Therapeutics join forces on first-in-class combination for solid tumours

Algorae Pharmaceuticals secures new supply of chemotherapy for Australia through Dr Reddy’s partnership

An interview that reminds us of the missing discussion in Australia

Neurizon Therapeutics entering 'a promising new horizon” as ALS program advances

Slade Pharmacy marks anniversary with record research contributions at conferences

US secures significant price reductions on 15 medicines in second round of medicare negotiations

The US and UK edging closer to an agreement on pharmaceutical pricing